Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-V ECMO in Refractory Septic Shock with ARDS
NCT04555798Phase 2Completed
- Start
- Feb 2022
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 arms). Primary endpoints: Number of patients weaned from ventilators at 2 weeks and Number of patients discharged from ICU at 2 weeks. Started Feb 2022; status: completed.
Beyond the preview
Go deeper on NCT04555798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04555798.